VALID Accommodations for Academic Medical Centers and Other Lab Tests

Bobby Patrick, AdvaMed’s SVP of Government & State Affairs and Alliance Development, on why #MTC25 is the can’t-miss moment to see the power of coalitions in action — where patients, policymakers, and innovators come together to share stories, shape policy, and spark alliances that last well beyond San Diego.

WASHINGTON, D.C.—AdvaMed, the medtech association, today announced a town hall featuring FDA Center for Devices and Radiological Health (CDRH) Director Michelle Tarver and fellow CDRH senior leaders at The MedTech Conference hosted by AdvaMed in San Diego in October. The town hall participants will update the audience on the center’s strategic direction and priorities and take questions.

Zach Rothstein, Executive Director of AdvaMedDx, on why this year’s diagnostics programming comes at an inflection point for IVD leaders — with regulatory modernization, reimbursement reform, and breakthrough technologies creating unprecedented opportunities to shape the future of health care.

WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medtech innovators, today urged the Centers for Medicare and Medicaid Services (CMS) to fix “serious flaws” in its proposed rule to restart competitive bidding for durable medical equipment in Medicare, citing risks to patient safety, fewer product choices for beneficiaries, and cost increases that would result if the rule stands. 

Thousands of K-12 students returning to school this fall will face a cell phone use ban during instructional hours. Diabetes monitoring deserves an exception.

WASHINGTON, D.C.—AdvaMed, the Medtech Association, is among 67 stakeholder groups, including patient advocacy groups and state medtech and life sciences associations, urging the Centers for Medicare and Medicaid Services (CMS) to create a timely, streamlined pathway for Medicare patients to access FDA-authorized breakthrough medical technology. 

A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.

WASHINGTON, D.C.—AdvaMed, the medtech association, today welcomed the kickoff of the latest Medical Device User Fee Amendments (MDUFA) discussion at a public meeting at FDA headquarters. Three AdvaMed senior staff members encouraged the agency to build on the successes of the prior five such agreements to ensure the next agreement, MDUFA VI, delivers strong results for the American public.